Home
About Us
Subject
Browse
0
Sign In
Ibdjnl/9
Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies
Article
Year: 2020
Pages: 11
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
Article
Year: 2020
Pages: 14
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program
Article
Year: 2020
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management
Article
Year: 2020
Pages: 12
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info